In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Eiger Bio Pharmaceuticals, Inc.. Trade Record

NASDAQ:EIGR Eiger Bio Pharmaceuticals, Inc. stock gains 14.73% Exit Oct 16, 2017 a Trade Record by priceseries

Trade Chart
Trade Chart EIGR Sep 29, 2017, priceSeries
About Eiger Bio Pharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on providing various products for the treatment of orphan diseases in the United States. It portfolio of products include Sarasar, an indication for the hepatitis delta virus infection; Exendin, which is used for the treatment of hypoglycemia associated with bariatric surgery; and Bestatin that is used for the treatment of pulmonary arterial hypertension and lymphedema, which are under Phase II clinical trials. The company was founded in 2008 and is headquartered in Palo Alto, California.

Trade Information
Trade Type
LONG
ReliabilityScore™
97.56
Entry Date
Sep 29, 2017
Entry Price
11.00
Sell Date
Oct 16, 2017
Sell Price
12.62
Net Gain
14.73%
Hold Time
11 Trading Days